Feasibility of a combination of high dose chemotherapy ifosfamide, carboplatin, etoposide (ICE) plus stem cells and bevacizumab in refractory sarcoma and germ cell tumors.

被引：0
|
作者：
Jordan, K [1 ]
Kegel, T [1 ]
Mueller, LP [1 ]
Kinitz, I [1 ]
Schmoll, HJ [1 ]
机构：
[1] Univ Halle Wittenberg, Halle Saale, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：833S / 833S
页数：1
相关论文
共 50 条
  • [31] A phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ cell tumors.
    Bedano, PM
    Brames, MJ
    Williams, SW
    Einhorn, LH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 384S - 384S
  • [32] Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome
    J Beyer
    O Rick
    S Weinknecht
    D Kingreen
    K Lenz
    W Siegert
    Bone Marrow Transplantation, 1997, 20 : 813 - 819
  • [33] Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: Incidence and implications for hematologic recovery and clinical outcome
    Beyer, J
    Rick, O
    Weinknecht, S
    Kingreen, D
    Lenz, K
    Siegert, W
    BONE MARROW TRANSPLANTATION, 1997, 20 (10) : 813 - 819
  • [34] Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Lymphomas
    Zhou, Ping
    Liu, Peng
    Zhou, Sheng-Yu
    He, Xiao-Hui
    Han, Xiao-Hong
    Qin, Yan
    Yang, Sheng
    Zhang, Chang-Gong
    Gui, Lin
    Yao, Jia-Rui
    Zhao, Li-Ya
    Zhang, Shu-Xiang
    Sun, Yan
    Shi, Yuan-Kai
    CHINESE MEDICAL JOURNAL, 2015, 128 (18) : 2498 - 2504
  • [35] Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Lymphomas
    Zhou Ping
    Liu Peng
    Zhou Sheng-Yu
    He Xiao-Hui
    Han Xiao-Hong
    Qin Yan
    Yang Sheng
    Zhang Chang-Gong
    Gui Lin
    Yao Jia-Rui
    Zhao Li-Ya
    Zhang Shu-Xiang
    Sun Yan
    Shi Yuan-Kai
    中华医学杂志英文版, 2015, 128 (18) : 2498 - 2504
  • [36] High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study
    S Kleiner
    A Kirsch
    I Schwaner
    D Kingreen
    N Schwella
    D Huhn
    W Siegert
    Bone Marrow Transplantation, 1997, 20 : 953 - 959
  • [37] Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantation
    Agaliotis, DP
    Ballester, OF
    Mattox, T
    Hiemenz, JW
    Fields, KK
    Zorsky, PE
    Goldstein, SC
    Perkins, JB
    Rosen, RM
    Elfenbein, GJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 314 (05): : 292 - 298
  • [38] High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study
    Kleiner, S
    Kirsch, A
    Schwaner, I
    Kingreen, D
    Schwella, N
    Huhn, D
    Siegert, W
    BONE MARROW TRANSPLANTATION, 1997, 20 (11) : 953 - 959
  • [39] Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors
    Nieto, Y.
    Tu, S. -M.
    Bassett, R.
    Jones, R. B.
    Gulbis, A. M.
    Tannir, N.
    Kingham, A.
    Ledesma, C.
    Margolin, K.
    Holmberg, L.
    Champlin, R.
    Pagliaro, L.
    ANNALS OF ONCOLOGY, 2015, 26 (10) : 2125 - 2132
  • [40] Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors
    Mardiak, J
    Fuchsberger, P
    Lakota, J
    Sálek, T
    Sycová-Milá, Z
    Drahokoupilová, M
    Baláz, M
    Koza, I
    NEOPLASMA, 2000, 47 (04) : 239 - 243
12345